Ionis Pharmaceuticals Inc
(NAS:IONS)
$
35.91
-0.42 (-1.16%)
Market Cap: 5.74 Bil
Enterprise Value: 4.73 Bil
PE Ratio: 0
PB Ratio: 8.65
GF Score: 40/100 Ionis Pharmaceuticals Inc at Wells Fargo Healthcare Conference Transcript
Sep 06, 2023 / 04:45PM GMT
Release Date Price:
$39.79
(+1.14%)
Yanan Zhu
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
Great. Thanks, everyone, for being here. My name is Yanan Zhu, and I'm one of the biotech analysts here at Wells Fargo. We're privileged to have the management team of Ionis Pharmaceuticals with us today for a fireside chat. And with me here are Beth Hougen, CFO; and Onaiza Cadoret, Chief Global Product Strategy and Operations Officer. Thanks, Beth and thanks, Onaiza, for being here.
Elizabeth L. Hougen
Ionis Pharmaceuticals, Inc. - Executive VP of Finance & CFO
Of course.
Onaiza Cadoret;Manier
Ionis Pharmaceuticals, Inc. - Executive VP, Chief Global Product Strategy & Operations Officer
Thank you.
Questions & Answers
Yanan Zhu
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
So a lot to talk about. I hope -- I was wondering if we can dive right in, into the eplontersen polyneuropathy U.S. approval and launch. I have a set of
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot